- Capital Cube•2 months ago
Click here to see latest analysisCryo-Cell International, Inc. reports financial results for the quarter ended May 31, 2016.HighlightsSummary numbers: Revenues of USD 5.77 million, Net Earnings of USD 0.64 million.Gross margins widened from 72.19% to 74.49% compared to the same period last year, operating (EBITDA) margins now 16.55% from 13.11%.Change in operating cash flow of […] (Read more...) The post Cryo-Cell International, Inc. :CCEL-US: Earnings Analysis: Q2, 2016 By the Numbers : July 26, 2016 appeared first on CapitalCube.
- Business Wire•2 months agoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Claims against Cryo-Cell International, Inc. and Advises Investors to Contact the Firm
Khang & Khang LLP announces that it is investigating claims against Cryo-Cell International, Inc. . The investigation focuses on whether the Company and its officers violated Delaware law.
- GlobeNewswire•2 months ago
OLDSMAR, Fla., July 11, 2016-- Cryo-Cell International, Inc., the world’ s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended ...
Cryo-Cell International, Inc. (CCEL)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||3.95 - 3.95|
|52wk Range||3.89 - 4.10|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||4.56|
|Avg Vol (3m)||3,944|
|Dividend & Yield||N/A (N/A)|